Sylvia Pasieka, NP
Nurse Practitioners (Acute Care Nurse Practitioner)
- Medicare participating
At a glance
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 23
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Acute Care Nurse Practitioner primary
NJ license 26NJ00417600 · NY license 430578 -
Registered Nurse
NJ license 26NR11720200 · NY license 640626-1
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Hackensack Meridian Health Medical Group - Specialty Care PC (1,922 clinicians)
- Totowa Cancer Center (10 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 23
- Services billed
- 23
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 32 | 32 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Hackensack, NJ | 69 |
| Oxycodone Hcl Other prescribers in Hackensack, NJ | 57 |
| Naproxen Other prescribers in Hackensack, NJ | 48 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 36 payments worth $920 in total to this clinician.
| Seagen Inc. | $179 |
|---|---|
| Sanofi-aventis U.S. LLC | $95.95 |
| Incyte Corporation | $90.28 |
| AstraZeneca Pharmaceuticals LP | $84.15 |
| Janssen Biotech, Inc. | $70.99 |
| Tersera Therapeutics LLC | $69.37 |
| Pfizer Inc. | $57.00 |
| Stemline Therapeutics Inc. | $54.32 |
| Food and Beverage | $645 |
|---|---|
| Education | $275 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Seagen Inc. Jun 17, 2025 | Education in-kind | $99.00 |
| Sanofi-aventis U.S. LLC Oct 20, 2025 | Education SARCLISA · Oncology · in-kind | $95.95 |
| Seagen Inc. Sep 4, 2025 | Education in-kind | $80.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.